Emotional eating is another hurdle
Consultation Format: Asynchronous (Most Common): Complete detailed questionnaire online Provider reviews within 24-48 hours Responds with questions or approval Can message with questions Live Video/Phone: Scheduled appointment (15-30 minutes) Real-time discussion with provider Ask questions directly Decision made during visit What Provider Assesses: Eligibility for GLP-1 therapy Which medication is best for you Starting dose Contraindications Realistic expectations Commitment to treatment Step 4: Choose Your Medication Decision Framework: Choose Semaglutide If: Want excellent results at lowest cost Need to lose 20-50 pounds Budget is primary concern ($199/month) Have cardiovascular disease Choose Tirzepatide If: Want maximum results Need to lose 50+ pounds Can afford $349/month Want most effective medication Your provider will help you decide based on your goals, health status, and budget
Shelf life comparison table The table above makes one thing clear
GLP-1RA Liraglutide Semaglutide Efpeglenatide Glucose lowering effect CV system protection effect Kidney protection effect Nonalcoholic fatty liver disease GIP/GLP1 receptor coagonists: tirzepatide Amylin/GLP1 receptor coagonists: CagriSema (cagrilintide+semaglutide) Glucagon/GLP1 receptor coagonists: survodutide GIP/GLP1/glucagon receptor triple coagonists: retatrutide Obesity is a disease that can be treated with targeted pharmacotherapy in addition to lifestyle modification and behavioral interventions
the players overweight on filings with no disclosed asset are the ones most likely to either announce a surprise clinical program or trade into a pure-licensing business model
5-12 The most common patient-reported adverse effects (AEs) associated with GLP-1 RAs and dual GIP/GLP-1 RAs are gastrointestinal (GI) in nature and may include abdominal pain, constipation, diarrhea, nausea, and vomiting
